World s first plant-based COVID-19 vaccine to be launched by Philip Morris-backed firm econotimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from econotimes.com Daily Mail and Mail on Sunday newspapers.
Families eager for results as drug companies test vaccines for use on children, teens msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
TORONTO At age 70, retired nurse Donna Lessard can expect to be towards the front of the line for a COVID-19 vaccine when supply and distribution expands in coming months. But instead, she s opted for an unproven vaccine candidate she can have now a two-dose product by the Quebec City-based biopharmaceutical Medicago currently running Phase 2 clinical trials. Because the trials are blinded, the Montrealer doesn t know if last month she received a second dose of the prospective vaccine or a placebo, and may not know for a year well after most Canadians are expected to receive one of several licensed vaccines.
Cassandra Szklarski
Retired nurse Donna Lessard is shown in a recent handout photo provided by Lessard. THE CANADIAN PRESS/HO-Donna Lessard MANDATORY CREDIT February 07, 2021 - 4:00 AM
TORONTO - At age 70, retired nurse Donna Lessard can expect to be towards the front of the line for a COVID-19 vaccine when supply and distribution expands in coming months.
But instead, sheâs opted for an unproven vaccine candidate she can have now â a two-dose product by the Quebec City-based biopharmaceuticalMedicago currently running Phase 2 clinical trials.
Because the trials are blinded, the Montrealer doesnât know if last month she received a second dose of the prospective vaccine or a placebo, and may not know for a year â well after most Canadians are expected to receive one of several licensed vaccines.